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Abstract
Spatial gradients of diffusible signalling molecules play crucial roles in controlling di-
verse cellular behaviour such as cell differentiation, tissue patterning and chemotaxis.
In this paper, we report the design and testing of a microfluidic device for diffusion-
based gradient generation for cellular assays. A unique channel design of the device
eliminates cross-flow between the source and sink channels, thereby stabilising gradients
by passive diffusion. The platform also enables quick and flexible control of chemical
concentration that makes highly dynamic gradients in diffusion chambers. A model
with the first approximation of diffusion and surface adsorption of molecules recapitu-
lates the experimentally observed gradients. Budding yeast cells cultured in a gradient
of a chemical inducer expressed a reporter fluorescence protein in a concentration-
dependent manner. This microfluidic platform serves as a versatile prototype applica-
ble to a broad range of biomedical investigations.
∗To whom correspondence should be addressed
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1. Introduction
Biochemical gradients are ubiquitous in biological systems. Gradients convey spatial and
temporal information and function as cues for cellular decisions such as differentiation, pro-
liferation and chemotaxis. Knowing how cells respond to them is thus fundamentally impor-
tant to biomedicine and biotechnology applications. A well-studied example of biochemical
gradients is that of morphogens that pattern embryonic tissues in a concentration-dependent
manner (reviewed in1–4). Recent experimental evidence has suggested that the response of
cells to morphogen gradients is regulated dynamically as the gradients change over time.2,4
Dynamics of morphogen gradients are therefore crucial for tissue patterning, as corroborated
by our theoretical study.5 As biochemical gradients in vivo may never be static, investiga-
tions of cellular response to gradients require experimental means to control gradients in a
dynamic manner to reproduce a natural cellular environment.
Microfluidic devices are becoming popular for studying gradients as they can generate
and maintain desired gradient profiles stably for a long period.6–8 A number of different de-
signs of microfluidic gradient generators have been proposed, which can be grouped into two
categories:8 flow-based9–13 and diffusion-based gradient generators.14–26 The flow-based gra-
dient is established by the diffusion at the interface of laminar flows. Diffusion-based designs
utilise a passive diffusion between a source and a sink flow channel or reservoir of chemicals,
which generates a linear gradient at steady states. Their advantages and disadvantages have
previously been discussed.7,8 For example, flow-based designs, unlike diffusion-based ones,
can generate gradients of complex profile and maintain them stably for a prolonged time.
The method of creating such non-linear gradients can reveal unexpected cell behaviour, for
instance, in neutrophil chemotaxis.10,27
One of the major drawbacks of the flow-based gradient generators for cellular assays is
that cell-to-cell communication by diffusible factors is disrupted by continuous flow as such
factors are washed away. Cells also experience a flow-induced shear stress, which may affect
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cell behaviour. Diffusion-based designs can overcome these problems and are appropriate for
analysing the cell’s response to gradients where autocrine or paracrine cell signaling plays
an important role. A typical diffusion based design features rectangular chambers between
a source and a sink flow channel. In devices with such a design,18,28 a technical difficulty is
to minimize the unwanted cross-flow between the source and the sink to maintain a stable
gradient.24 Different schemes have been proposed to rectify this problem of flow-induced
perturbation: membranes,14,20 hydrogels17 or micropillars19,22 between channels and a diffu-
sion chamber; microfluidic ”jets” that inject small amounts of fluid with minimal flow over
cells;15 increased flow resistance across the chamber by reducing its height;19 embedding
cells in a collagen matrix;19,28 a contact zone to balance the pressures of the source and sink
streams;16 a two-layered device with micro-channels in the top layer and a buried diffusion
chamber in the bottom layer.23
Another notable solution for this technical challenge was put forward recently by Frank
and Tay.24 In their flow-switching device, only one side of the chamber is exposed to the flow
channels at a time. By alternate switching of the on-chip membrane valves separating the
chamber and the source/sink channels, gradients were established while a cross flow in the
chamber was eliminated. Its capability of generating extremely stable spatial gradients was
demonstrated with molecules such as lipopolysaccharides (LPS), tumour necrosis factor-α
(TNF-α) and platelet-derived growth factors (PDGF) along with a fluorescent tracer (FITC-
dextran, 40 kDa).24
The reliable maintenance of gradients by the flow-switching scheme, however, depends
on the size of diffusing molecules (i.e., diffusion coefficients), the length of a chamber and
the duration between valve switching, as gradients degrade by diffusion in a closed chamber.
Our calculation suggests that in a chamber of 1 mm length with 60 seconds between flow-
switching (as specified in24), molecular weights need to be larger than ∼3.5 kDa (Section 4);
many biologically active molecules fall below this threshold. Microfluidic gradient devices for
unicellular organisms like yeast or slime mould Dictyostelium usually have diffusion cham-
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bers of less than 1 mm in length (for example18,21). In a shorter chamber of 500 µm, unless
using a shorter period of switching cycles, it may not be possible to maintain gradients of
any biochemicals reliably with the flow-switching scheme (Section 4). The interval of flow-
switching could be shortened in the flow-switching device for fast-diffusing (low molecular
weight) molecules. Yet, it makes it necessary to reduce the number of parallel gradients that
can be controlled in a single chip, compromising one of the very advantages of its design.
In this paper we used theoretical models and numerical simulations to aid the design
and testing of a device for diffusion-based gradient generation. Our design has a channel
junction upstream of the diffusion chambers, where the source and sink flows are merged to
create a laminar flow away from the cell chambers; this enables precise balancing of flows in
the source and sink channels thereby eliminating cross flows in the chambers. A similar idea
was adopted in the device developed by Atencia et al.23 and Irimia et al.;16 their device also
merges the source and sink flows separated by a laminar interface, which in turn generate
a gradient in the diffusion chambers downstream. In their device, however, there is a diffu-
sive mixing between the merged streams, which may be an issue depending on the length
of the laminar interface and the flow rates. To avoid a diffusive mixing, our device has a
thin separation wall that splits the merged source/sink flows towards the cell chambers. We
also adopted the design features reported previously including chaotic mixer channels29 with
the so-called Dial-A-Wave (DAW) junction.30 The modular combination of these preexisting
microfluidics parts with the unique channel design allows rapid and independent control of
biochemical concentration in the source/sink flows.
We demonstrate the capability of our device using fluorescent tracer dyes and yeast cells
harbouring a fluorescent protein reporter gene that are exposed to a gradient of the in-
ducer doxycycline (Dox). Unlike the flow-switching device, our design allows stable gradient
generation irrespective of the molecular mass, as well as a rapid and dynamic control of
gradients.
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2. A model of diffusion-based gradient with adsorption
We consider the diffusion of molecules that can be adsorbed on the exposed surface (e.g.
PDMS). The process of adsorption can be described by the law of Langmuir.31 The theory
of Langmuir assumes that molecules can only be adsorbed on the solid surface that are
not yet covered by the molecules. Let φ be the fraction of surface already occupied by the
molecules. The flux of molecules J1 being adsorbed by the surface is:
J1 = k1uf (1− φ), (1)
where k1 is a rate constant and uf is the local concentration of the molecule in solution. The
backward flux J2 of the adsorbed molecules from the surface is proportional to φ:
J2 = k2φ, (2)
where k2 is another rate constant. We take these fluxes J1 and J2 into account to model the
diffusion dynamics.
The diffusion term can be described by Fick’s second law. The question is how we can
combine the law with fluxes J1 and J2 . The height (H) of the cell chambers in our microfluidic
device is much smaller than the width (W) and length (L, which is parallel to the direction
of diffusion); H = 4.5µm,W = 100 µm,L = 300 to 700 µm. The characteristic diffusive
mixing time (τ) of a substance across the height of the chamber is given by τ ∼ H2/D,
where D is a diffusion coefficient. D is typically on the order of 10−6 to 10−5cm2s−1 (102 to
103 µm2s−1) in aqueous solution, for which τ ∼ 0.02 to 0.2 s. This is orders of magnitude
lower than the diffusion time across the length of L or W. The sides of the chamber (PDMS)
may also influence the gradient profile. But this boundary effect was noticeable only very
close to the PDMS because the concentration of molecules averages out along the width of
the chamber by diffusion, as observed in the gradient profiles in the experiments described
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later (for example, see Fig. 5c). We can thus approximate the diffusion with adsorption by
a model in one-dimension described by Eqs. 3-5.
∂uf
∂t
= D∆uf − J1 + J2 − kduf , (3)
∂ua
∂t
= J1 − J2 , (4)
φ =
ua
A
(5)
where ∆ is the Laplacian operator, D is a diffusion coefficient, kd is the decay (degradation)
rate constant, ua is the local concentration of the adsorbed (immobile) molecule, and A is
the maximal ua (that is, the surface concentration at saturation). At steady state (t =∞),
from Eqs. 3 and 4:
D∆uf (x ,∞)− kduf = 0, (6)
J1 = J2 . (7)
From Eq. 6, the steady state (concentration) gradient in solution is independent of adsorp-
tion. A steady state solution can be obtained using a boundary condition, which corresponds
to the concentration at the left edge (x = 0) and the right edge (x = L) of a diffusion cham-
ber:
uf (0, t) = c1, uf (L, t) = c2, (8)
where c1 and c2 are constants. For fluorescent tracers, we assume kd = 0 as their decay due
to photobleaching is negligible compared to the mass transfer by diffusion from the parallel
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channels. Assuming kd = 0 and solving Eqs. 6-8, the steady state solution is:
u¯f = c1 +
c2 − c1
L
x , (9)
u¯a =
A u¯f
k2
k1
+ u¯f
(10)
=
A u¯f
1
ka
+ u¯f
, (11)
where u¯f = uf (x ,∞), u¯a = ua(x ,∞); ka is the adsorption coefficient defined as ka = k1k2 (Fig.
1).
Therefore, the steady state gradient in solution is linear (and independent of adsorption)
in the absence of molecular decay. In the presence of a decay, the gradient is an exponential
decay curve. In the presence of adsorption, however, the effective diffusion would be slower
than predicted by the diffusion coefficient D. For a fluorescent molecule, the total fluorescence
is proportional to u¯f + u¯a , which shows a characteristic concave profile at the steady state
(Fig. 1). The gradient of the fluorescent tracer Sulforhodamine 101 (SR) is concave as we
later show, indicating the adsorption of SR on the surface of the chamber.
3. Estimation of diffusion coefficients
Evans et al.32 provides an equation to calculate diffusion coefficients of small molecules from
their molecular weights:
D =
kBT (
3α
2
+ 1
1+α
)
6pi η 3
√
3MW
4pi ρeffNA
, α =
3
√
MWs
MW
, (12)
where η is the dynamic viscosity of solvent (water), ρeff is the effective density of a small
molecule, kB is the Boltzmann constant, NA is the Avogadro number, T is the absolute
temperature; MWs and MW are the molecular weights of the solvent and the molecule
for which we want to estimate the value of D , respectively (the function plotted in Fig.
7
2a). They showed that calculated coefficients were good estimates of the values determined
experimentally.32
To calculate the diffusion coefficient of Sulforhodamine 101 (SR; MW = 606.71 Da) and
Cascade Blue hydrazide (CB; MW = 527.47 Da), we used the following values of constants
and parameters: T = 298 K, η = 0.89 × 10−3 kg m−1 s−1, ρeff = 619 kg m−3,MWs = 18 ×
10−3 kg mol−1. The estimated values of diffusion coefficients were 413 µm2 s−1 for SR and
437 µm2 s−1 for CB.
To estimate the diffusion coefficient of FITC-dextran (MW = 10 kDa), we used a power
law relationship:
D = a (MW ) b (cm2 s−1) (13)
with a = 2.71 × 10−5, b = −0.37.33 The calculated value of the diffusion coefficient is
8.97× 10−7 cm2 s−1 = 89.7 µm2 s−1.
4. Decay of gradients in a closed chamber
The flow-switching scheme for gradient generation and maintenance described by Frank and
Tay24 operates by alternate opening and closing of the on-chip membrane valves. The valves
are open for 1 s each every 2 min, therefore, chambers are isolated from the source and sink
channels for ∼1 min. We calculated how much a gradient diverges from a steady state during
this period as they decay by diffusion in a confined environment. This was done by solving
the diffusion equation ∂u
∂t
= D∆u with a boundary condition:
∂u
∂x
∣∣
x=0
=
∂u
∂x
∣∣
x=L
= 0, (14)
and an initial condition, which is a linear gradient:
u(x, 0) =
Cx
L
, (15)
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where C is a constant. In the flow-switching device, L = 1 mm. Fig. 2b shows the plot of
the solution for D = 100 and 500 µm2 s−1 (with C = 1). % error is the fraction of the area
diverged from the linear gradient after 60 s, which is plotted against diffusion coefficient in
Fig. 2c. For a chamber with L = 1000 µm, D = 208.4 µm2 s−1 results in 5 % error. From
Eq. 12, this corresponds to the molecule weight of ∼3.5 kDa.
5. Device design
The design is based on the devices developed by Paliwal et al.18 and Ferry et al.30 The
microfluidics device consists of main channels, a pair of mixer modules and rectangular
diffusion/cell chambers (Fig. 3). Flows in the chip are controlled by hydrostatic pressure.
A single unit of the controller holds two media reservoirs that are connected to a pair of
inlet ports (M1-M2 or M3-M4 in Fig. 3a). Media inputs from these ports flow through
a “Dial-A-Wave” (DAW) junction30 (Fig. 3a and b). At the DAW junction two media
inputs are combined and mixed while passing through a staggered herringbone mixer (SHM)
channel29 (Fig. 3a (highlighted in green) and c). The mixing ratio is controlled precisely
by the hydrostatic pressure controller adopted from Ferry et al.30 (Fig. S7). The mixer
modules are positioned symmetrically, which feed two mixed media to a channel junction in
the middle of the device (which we call the “split junction”; Fig. 3d). See the Supplementary
movie SplitJunction.avi, which is a time-lapse image sequence of SR fluorescence at the split
junction; the fluorescent dye was supplied as a triangle wave (5 min period, 2 cycles).
Once the mixed media reaches the split junction, the media flows towards the shunt port
(S) or down a pair of parallel channels leading to the diffusion chambers (highlighted in red
in Fig. 3a and f). The split junction has a separator wall that eliminates a diffusive mixing
of the two media flows (Fig. 3d and e). Without this separator wall, significant diffusive
mixing at the laminar interface was observed (Supplementary material, Fig. S1c, d). The
separation wall at the split junction may be extended for an additional length (perhaps 10
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to 100 µm, which should be determined experimentally). This modification allows counter
flows towards the shunt port to eliminate the possibility of minor diffusive mixing between
the left and right channels at the end of the separation wall.
The split junction is also connected to cell outlet ports through serpentine channels (C1
and C2, Fig. 3a). Once cells are loaded in the chip, C1 and C2 ports are closed by small
binder clamps on the Tygon tubes just outside of the chip to stop the flows through these
ports. The parallel channels act as a source and a sink for diffusion through the rectangular
chambers of different lengths. The parallel flows merge downstream of the chambers towards
the waste port (W).
At the split junction a laminar flow is created towards the shunt port (Fig. 3e). Together
with a laminar flow at another junction downstream of the chambers towards the waste port
(Fig. 3h), the laminar flow interface serves as an indicator of the balance of the right and
left media flows towards the diffusion chambers. The position of the laminar flow interface
can be adjusted by fine-tuning the height of the media reservoirs on the hydrostatic pressure
controllers thereby equalising the left-right pressure balance. This eliminates the cross-
flow across the chambers and enables an establishment of stable diffusion-based chemical
gradients.
6. Materials and Methods
6.1. Microfluidic device fabrication
The microfluidic devices were fabricated using conventional soft-lithography methods with
poly(dimethylsiloxane) (PDMS).34 Silicon wafers (10 cm diameter) patterned with SU8 pho-
toresist were custom-ordered from Kelvin Nanotechnology Ltd. (Glasgow, UK). AutoCAD
(Autodesk) was used to draw the device design. CAD files are available on request. Device
chips were made by pouring PDMS (Sylgard 184, Dow Corning; 10:1 mix with curing agent)
over the mold. PDMS was then degassed, cured at 70 ◦C for 3 hours, peeled from the mold
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and cut into individual chips. Holes for media inlets and outlets were punched through the
chip using a sharpened Harris UNI-CORE™ biopsy punch (0.5 mm). Dust was removed from
PDMS chips and coverslips by ionizing air (nitrogen) gun (Top Gun, Simco) before assem-
bly. PDMS chips and coverslips were bonded together after treatment with a plasma cleaner
(Zepto ONE, Diener Electronic; HF generator 50 % (∼15 W), 30 seconds). Assembled chips
were then cured further at 60 ◦C overnight. Microbore tubing (ID/OD 0.02”/0.06”; Cole-
Parmer, Tygon S-54-L) was used to connect a PDMS chip and media reservoir syringes.
Hydrostatic pressure actuators are fabricated according to Ferry et al.,30 which is controlled
by a Raspberry Pi computer (Raspberry Pi 2 Model B); https://www.raspberrypi.org)
and driven by a Java code modified from30 (http://biodynamics.ucsd.edu/dialawave/).
The Java source code is available upon request. Setup and operation protocol of the platform
is described in detail in Supplementary material Section 5.
6.2. Yeast strains and media
Two diploid strains of yeast S. cerevisiae, MM169 and MM201, were used in this study,
each of which harbours a fluorescent protein reporter gene (destabilised version of yVenus,35
an enhanced YFP). MM169 also has a gene encoding the transcriptional activator rtTA of
the Tet-On system35 while MM201 has a tandem array of genes encoding rtTA and TetR-
Ssn6 (a synthetic transcriptional repressor) that constitutes the activator/repressor dual
system.36 See Supplementary material Fig. S6 for the illustration of these gene constructs
(Fig. S6a for MM169; Fig. S6c for MM201), which were all integrated in the genome using
the method described previously.35,37 Details of the construction of these strains will be
described elsewhere. For microfluidics experiments, yeast cells were first grown overnight at
30 ◦C in 10 ml synthetic complete media with raffinose (SMR), the composition of which is
identical to the synthetic complete (SC) media38 except glucose is replaced with raffinose (2
%; Formedium, cat. no. RAF01). On the following day the SMR cell culture was spun down
at 3,000 g for 10 min and resuspended in 2 ml synthetic complete media with maltose (SMM;
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same as SC with maltose (2 %; BD Difco cat. no. 216830) replacing glucose) supplemented
with BSA (Sigma A7906; final concentration at 0.01 %). Cells were then injected into a
microfluidic device by 20 ml syringe through 10 cm of Tygon tube connected to the waste
port. The cell loading procedure is detailed in Supplementary material Section 5.3. Once
cells were loaded in the device, SMM was used for cell growth. Doxycycline was added to
one of the reservoir media syringes to the final concentration of 2 µg/ml. For shake flask
experiments (Supplementary material Fig. S6) yeast strains were cultured in 10 ml of SMR
at 30 ◦C overnight. These precultures were then diluted to OD600 = 0.4 in 10 ml SC, SMR
or SMM and continued to be grown at 30 ◦C. Each cell culture was split after 2 hours and
either treated with doxycycline (Dox) (at the final concentration as indicated in Fig. S6) or
left untreated. After further 7 hours culture at 30 ◦C, images were captured by fluorescence
microscopy using the same imaging system for microfluidics experiments.
6.3. Microscopy and data analysis
Fluorescent tracer molecules were used at the following final concentrations in SC or SMR
media: Cascade Blue hydrazide (CB; Trilithium salt, Thermo-Fisher) at 20 µM, Sulforho-
damine 101 (SR; Sigma-Aldrich S7635) at 10 µg/ml and Fluorescein-dextran (FD; molecular
weight 10,000, Sigma-Aldrich FD10S) at 1 mg/ml. For microfluidic experiments with yeast
cells, CB was added to SMM. For microscopy we used a Zeiss Axio Observer Z1 microscope
equipped with an incubation chamber, CCD camera (Coolsnap HQ2, Photometrics) and
Axiovision software (v4.8.2 SP3 (08-2013)). Either 20x (Ph2) or 40x (Ph3) objective was
used for imaging. Fluorescence images were captured using Zeiss 62 HE BFP/GFP/HcRed
filter set (excitation filter: BP370/40 for CB; BP474/28 for FD and Venus; BP585/35 for
SR).
To quantify the gradients of fluorescent tracers, a rectangular region (width = 100 µm) in
the captured images corresponding to a single diffusion chamber was cropped using ImageJ
(version 1.50g). Average (total) pixel intensities were calculated along each single pixel line
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parallel to the main flow channels (orthogonal to the direction of diffusion). Fluorescence
intensities in the main flow channels are represented by the intensity of a single pixel line
parallel to the flows, approximately 20 µm away from the diffusion chamber’s edge. Theo-
retical calculations of channel flows and diffusion/adsorption models were performed using
Mathematica software (version 10.4, Wolfram Research).
7. Results and Discussion
7.1. Computer-controlled gradient of small molecules
First, to test the microfluidic platform, we used fluorescent dyes Sulforhodamine 101 (SR;
M.W. = 606.7 Da) and Cascade Blue hydrazide (CB; M.W. = 527.5 Da). We note that SR
and CB are relatively small molecules with similar molecular masses. Thus their diffusion
coefficients are also similar (estimated values are 413 µm2 s−1 for SR and 437 µm2 s−1 for
CB; see Section 3). SR and CB flowed through the left (SR) and right (CB) channels to
generate gradients (Fig. 4a).
The fluorescent dyes were supplied as square waves (Fig. 4b and c), which were controlled
independently. Fluorescence of CB and SR was quantified by fluorescence microscopy in one
of the chambers (300 µm in length). Note that a slight increase in CB fluorescence in the
left channels (arrows in Fig. 4c, upper panel) is due to a bleed-through of SR signal (see
Supplementary material Section 3). Fig. 4d and e show the fluorescence along the chamber
over time. The gradient of fluorescence is linear for CB while the one for SR is concave.
Similar gradients were detected in the other chambers of different lengths (data not shown).
If the mass transfer of a chemical occurs only by passive diffusion then it is predicted that
at the steady state a linear gradient is established in a rectangular chamber between source
and sink channels,24 as observed with CB (Fig. 4d). The most plausible explanation of the
concave profile of SR fluorescence is the adsorption of SR on the solid surface of the chamber
(Section 2). The detected SR fluorescence is the sum of the signals from the free molecules
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in solution and those adsorbed on the surface.
7.2. Diffusion in the presence of adsorption
The diffusion-adsorption in a chamber can be modelled by Fick’s law of diffusion and the
law of Langmuir that describes the equilibrium between the molecules in solution and the
adsorbing surface31 (see Section 2). This simple model recapitulates the observed fluores-
cence profiles of SR rather well. Fig. 4f and h show the fluorescence of SR (red) and CB
(blue) across the chamber over the 100 s period (10 s interval) after the tracer inputs were
switched off (Fig. 4f) or on (Fig. 4h). The observed fluorescence profiles over time are
qualitatively similar to the simulation results (Fig. 4g and i). Although SR and CB have
similar diffusion coefficients, it took much longer to establish a steady state gradient for SR
than CB. Thus, when adsorption occurs, the effective diffusion rate of a molecule can be
smaller than predicted by assuming a free diffusion. In this particular experiment with a
period of 1200 s, the SR gradient did not reach the steady state profile while the CB gradient
did. In most cases, we have no prior knowledge about the adsorption of the molecules of
interest at the solid-liquid interface. Therefore, a fluorescent tracer of a similar molecular
weight is not necessarily a good proxy of the molecule to be analysed by gradient generation.
If a biochemical of interest interacts with the substrate such as PDMS (for example, retinoic
acid39) a careful analysis of gradient dynamics may be necessary to interpret experimental
results properly. Even so, the steady-state gradient of molecules in solution is predicted to
be linear and independent of adsorption (Fig. 1).
7.3. Generation of a gradient of larger molecules
Next, we tested a gradient generation using FITC-dextran (FD; M.W. = 10 kDa) and CB as
a reference. The estimated diffusion coefficient of FD is 89.7 µm2 s−1 (Section 3). FD and CB
were supplied in square waves (300 s out of sync) to the left (FD) and right (CB) channels
(Fig. 5a, upper panel). Note that we detected a significant bleed-through of FD signal in
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the CB fluorescence (Fig. 5a, arrows in lower panel; see Supplementary material), which
hampers an accurate measurement of CB fluorescence in the presence of FD. Fluorescence
was measured in a chamber of length = 500 µm.
Fig. 5d and f show the fluorescence profile across the chamber for every 10 s over the 100
s periods as indicated (grey bars in Fig. 5a). Fig. 5e and g are the corresponding gradients
predicted by a passive diffusion without adsorption. The CB gradient in the absence of FD
(at t = 410 s) was linear (Fig. 5d). By contrast, FD gradients approached a sigmoidal
shape after the FD input to the left channel was switched on (Fig. 5d, green curves). The
fluorescence intensity profile in the chamber after the input was switched off (Fig. 5f) is
similar to the one theoretically predicted (Fig. 5g) except the flatter regions close to the
edges of the chamber (black arrows in Fig. 5d, f).
The flatter regions in the concentration profile are also evident in contour plots across the
chamber (Fig. 5c, indicated by arrows). These regions were due to inward flow trajectories
near the edges (illustrated in Fig. 5b), which creates advection dominated areas. Such
advection-dominated areas near the edges of diffusion chambers were reported previously
with FD of M.W. = 40 kDa.24 Apart from the difference due to the effect of advection, the
predicted gradient profiles (Fig. 5e, g) reproduced observed ones (Fig. 5d, f) quite well. The
fluorescence profile of CB is little affected by the inward flow, perhaps because its diffusion
is fast enough to counteract the effect of the advection.
7.4. Dynamic gradient generation
Next, we tested the capability of the microfluidic platform to generate a dynamic gradi-
ent. CB media supplied to the left and right channels were controlled independently, so
the gradient of varying magnitude, steepness and direction can be generated according to a
pre-programmed scheme. The chemical concentrations in the parallel channels (i.e., bound-
ary conditions) can be changed quickly, which was demonstrated in the response to square
wave input signals (see Supplementary material Section 2, Fig. S2 and the movie Square-
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WaveGrad.avi, which shows the dynamic gradient in Fig. S2). Fig. 6 shows an example of
a dynamic gradient of CB in a 300 µm chamber in response to trapezoid waves of inputs.
The Supplementary movie (TrapezoidWaveGrad.avi) provided online shows the time-lapse
image sequence of the gradient shown in this figure (1 sec interval, 301 frames = 300 sec; 20
fps). Pre-programmed schemes are not restricted to square or trapezoid waves. In fact, any
arbitrary function can be adopted to control the input concentration (mixing ratio) of the
substances of interest30 to change the magnitude and steepness of the gradient.
7.5. Gene expression in budding yeast cells in response to an in-
ducer gradient
We designed the microfluidic device in order to study the behaviour of engineered budding
yeast (S. cerevisiae) cells in chemical gradients. To test the microfluidic device for bioassays,
we cultured yeast cells in the diffusion chambers. The yeast strains harbour a reporter gene
encoding a fluorescent protein (Venus, a yellow fluorescent protein), which is expressed in
response to a chemical inducer Dox. In the media used for microfluidic experiments (SMM,
see Section 6 and Supplementary material Section 4), the doubling time of cell growth is 5.4
hours. As cells grow they gradually occupy the entire chamber and those pushed out of the
chamber are washed away by the flows in the main channels.
When cells were exposed to Dox uniformly, all cells expressed the reporter fluorescent
protein Venus (Fig. S5, at t = -225 min). After removing Dox from the chamber, the
fluorescence diminished rapidly (Fig. S4, compare t = -225 min and 0 min) indicating the
reporter gene expression was switched off. When Dox gradient was generated, expression
of Venus was observed in a population of cells close to the left channel, i.e. the source
of the Dox inducer (Fig. 7a). As the source concentration of Dox increased, the region
of expression expanded (Fig. 7a; the positions of the expression boundary with the initial
gradient with 0.2-0 µg/ml of Dox are indicated by red arrowheads). Images throughout the
whole experiment are shown in Fig. S4. Dox was supplied with CB as a tracer, which formed
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a gradient across the chamber with cells (Fig. 7b). Together, these results demonstrate a
generation of Dox gradient, which induced a reporter gene expression in yeast cells in a
chamber in a concentration-dependent manner.
When source (left) channel concentration of Dox was increased to 1 µg/ml, some cells
close to the sink (right) channel started to express the reporter gene (Fig. 7a, at 2670 min,
red bracket). This is most likely due to a fraction of Dox diffusing out of the chambers
upstream.
8. Conclusions
We have demonstrated the capability of our microfluidic device that can generate highly
dynamic diffusion-based gradients. A unique design of the “split junction” in this device
allows balancing of the flows in the source and sink channels, thereby eliminating unwanted
cross flows in the diffusion chambers that may disrupt gradient profiles and cell-to-cell signal-
ing. Together with the DAW mixer modules, the split junction enables independent, flexible
and rapid change of chemical concentrations in the source and sink channels. This dynamic
feature, as illustrated in Fig. 6, is a distinct advantage of our device design over those pre-
viously reported. Unlike the flow-switching device,24 our device can generate gradients of
fast-diffusing (low molecular weight) molecules.
Our device design, however, has some limitations that include: 1) the steady-state gra-
dient is limited to linear profiles; 2) precise balancing of left and right source/sink flows
requires the visualization of the laminar interfaces by fluorescent tracers. This prototype
device may also benefit from further design modification to maximise its performance. For
example, on-chip pneumatic valves instead of manual clamping of the tube would also sim-
plify the cell-loading process but the advantages need to be weighted carefully against adding
an extra layer of complexity.
We also showed that the adsorption of a molecule on the solid surface may greatly affect
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its gradient profile. Thus, a fluorescent tracer of a similar molecular weight is not always
a good proxy of the molecule to be analysed by gradient generation. As we only used a
simple inducible reporter gene expression in yeast (Fig. 7), we have not yet exploited the
full capacity of the device for bioassays. We expect this microfluidic device to be a versatile
prototype applicable to a broad range of biomedical investigations of cellular response to
gradients such as morphogenesis, chemotaxis or axon guidance.
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Supplementary Material
1. Design of split junction
1.1. Role of the separation wall
We tested three different designs of the split junction; other parts of the device are identical).
The overall performances of the designs v10 and v11 (Fig. S1a, b) were similar, but the
laminar flow at the junction was somewhat easier for observation to balance the flows with
the design v10, which has a separation wall (Fig. S1a). The separation wall is necessary to
prevent the diffusive mixing at the laminar interface, as evident in the design v9 (Fig. S1c,
d). We therefore used devices with the split junction v10 most of the time.
1.2. Time-lapse movie of flows at the split junction
The movie SplitJunction.avi (Supplementary content online) shows time-lapse images of SR
fluorescence at the split junction. The fluorescent dye was supplied as a triangle wave (5 min
period × 2 cycles). Note that the laminar flow interface was not affected as the concentration
of SR was altered.
2. Speed of media change in parallel channels
In our microfluidic chip, media composition can be changed quickly because the media
composition (i.e., mixing ratio) is controlled by the DAW junction and SHM channels on
chip. The time required to replace the media flowing through the parallel channels is thus
dictated by the flow rate in the channels. Typically it takes around 30 seconds to completely
replace the media in parallel channels after the execution of a computer program to change
the mixing ratio of input media. The concentration of chemical compounds at the ends
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of diffusion chambers is therefore controlled precisely and quickly. This is illustrated by
a gradient profile in a diffusion chamber (300 µm) in response to square wave signals of
CB (Fig. S2). The movie (SquareWaveGrad.avi) provided as Supplementary content online
shows the time-lapse image sequence of the gradient shown in this figure (10 sec interval,
183 frames = 30 min 20 sec; 20 fps).
3. Cross-bleeding of fluorescence signals
Due to the long tailed excitation spectra of Suoforhodamine 101 (SR) and Fluorescein-
dextran (FD), the excitation UV light for Cascade Blue (CB) also excites SR and FD flu-
orophore. For example, the SR signal bleeding is evident in Fig. S3; the increase of CB
signal on the left channel correlates with the rise of SR signal on the same channel (Fig.
S3A, arrows) rather than the CB signal on the right channel (Fig. S3A, blue dashed line).
Because of this signal bleeding, the steady-state fluorescence profile of CB is altered in the
presence of SR (Fig. S3B) or FD.
4. Carbon source for yeast cell growth in mocrofluidic
devices
We found CO2 production by yeast fermentation disrupts the operation of the platform
severely, as the air (CO2) in any parts of the system makes it impossible to control the flow
reliably. This limits the duration of an experiment. To circumvent the problem, we tested
various carbon sources to replace glucose in the standard synthetic media for yeast growth,
which include glycerol (3%), potassium acetate (1%), raffinose (2%) or maltose (2%) (see
Material and Methods in the main text). In normal shaking flask cultures, cell growth is
slower with raffinose (doubling time = 3.9 hours) than with glucose (2.4 hours). Cell growth
with maltose is slower than with those two carbon sources, with doubling time of 5.4 hours.
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Other than the slower growth, we found no aberrant morphology of cells with these three
carbon sources. Cell growth in synthetic media with glycerol or potassium acetate is even
slower than that in the maltose media (SMM).
We found that yeast cells need to be grown in raffinose media first before being cultured in
maltose media; if cells are inoculated into maltose media from a culture of glucose media di-
rectly, cells do not grow. This is perhaps because of a catabolite repression in the presence of
glucose. Derepression seems to happen in raffinose media, which allows growth with maltose
as a sole carbon source. Although raffinose media extends an operation time for microfluidic
experiments, fermentation slowly occurred, leading to an appearance of CO2 bubbles in the
system (especially in Tygon tubes). By contrast, maltose completely eliminated this problem
with yeast fermentation in microfluidics. We therefore decided to use SMM for microfluidic
experiments with yeast cells. The experiment shown in Fig. S4 and S5 (and Fig. 7 in the
main text) were performed using SMM. We then examined an inducible fluorescent protein
expression by a standard Tet-On system illustrated in Fig. S6A. Unexpectedly, we observed
a high background expression of the reporter yVenus in the absence of the inducer doxycy-
cline (Dox) when cells were cultured in media with raffinose or maltose (but not in glucose)
(Fig. S6B). This makes it difficult to distinguish the induced state from the non-induced
state. We therefore adopted an activator/repressor dual system36 illustrated in Fig. S6C.
This system suppressed the background expression of the reporter gene in all three media
tested in the absence of Dox (Fig. S6D). In SMM (and in raffinose media SMR), 0.1 µg/ml
of Dox was sufficient to induce the expression of yVenus.
5. Detailed methods for microfluidics
5.1. Materials
For media reservoirs connected to M1-M4, W and S ports, 50 ml luer lock syringes were used.
For C1 and C2 ports, 20 ml syringes were used. Syringe reservoirs were covered by Parafilm
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Table S1: Tygon tubes.
Ports Length1
M1-M4 1.3 m
S 1.2 m + 10 cm 2
W 1.2 m + 5 cm 2
C1, C2 0.8 m + 10 cm 2
1 Use appropriate lengths according to the
microscopy system available.
2 Short tubes are connected between the
longer one and the chip.
Table S2: Media and solutions for microfluidic operation.
Ports/Purpose Media/Solution Volume1
M1, M3 SMM + 20 µM CB + 2 µg/ml Dox 10 ml
M2, M4 SMM 10 ml
Cell loading SMM 5 ml
Priming/wetting chip SMM + 0.1% BSA 5 ml
C1, C2, S, W Water + 0.01% BSA 10 ml
1 Per port.
(pierced through by a needle) to avoid contamination. Syringes with media/solutions were
connected to Tygon tubes of appropriate lengths through 25Gx5/8” (0.5 mm x 16 mm)
needles (Table S1). For S, W, C1 and C2 ports, a short tube was inserted between the chip
and the longer tube through needle adaptors. This arrangement allows draining and replacing
syringe reservoirs if necessary. The needle adaptors were made by cutting 25Gx5/8” needles
by pliers and grinding off edges on a sandstone sharpener. Media/solutions (Table S2) were
filter-sterilised (0.2 µm pore size). The solutions were left in a 30 ℃ incubator to degas for
at least a few hours prior to the experiment. Note that even a tiny air bubble trapped in
needles or tubes may disrupt the pressure balance and make flows unsteady. Tubes were
connected to syringes, filled with media/solution by gravity flow and clamped at the ends
to stop the flow until being connected to a microfluidic chip.
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5.2. Setting up microfluidics
To prepare the device for operation the procedure below was followed (in a laminar air hood
to avoid contamination):
1. Affix a microfluidic chip on a solid base (e.g. by Blu-Tack®).
2. Draw 5ml SMM+0.1% BSA into 20 ml syringe and attach 25Gx5/8” needle. Remove
air from the syringe.
3. Attach a bent needle adaptor to a 10 cm tube and connect the other end to the syringe.
4. Drain the solution out of the tube/needle then insert the needle adaptor to the W port
of the chip.
5. Introduce the solution into the chip by gently pushing the plunger. Leave it to flow
until all the channels are wet and the solution begins flowing out from the other ports
(Fig. S7B).
6. Attach bent needle adaptors to each tube of the syringe reservoirs prepared above and
insert them into the ports in the following order: S → C1 → C2 → M2 → M4 → M1
→ M3. BSA in the solution for S, C1 and C2 ports (Table S2) blocks the surface to
prevent non-specific binding (adsorption) of CB and cells.
At this stage the microfluidic device was set up on the microscope/imaging system as
illustrated in Fig. S7A, except the syringe reservoir for the port W (still attached to a syringe
used to wet the chip). Syringe reservoirs attached to M1-M4 were set on the hydrostatic
controllers and those attached to C1, C2 and S were set up on a separate clamp stand. The
chip was kept lower than the syringes all the time to avoid air being introduced inside the
chip. The balances of M1/M3 and M2/M4 ports were also adjusted at this point. To do
this, tubes adjacent to C1 and C2 ports were clamped first and the syringe reservoir heights
were fine-tuned by looking at the laminar flow at the split junction (Fig. 1E).
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5.3. Loading yeast cells
Table S3: Pressure applied to each port.
Operation Ports Pressure1 (height: cmH2O)
Cell loading M1-M4 (closed2)
S (closed2)
C1, C2 14
W 14
Gradient generation M1-M4 71
(cell culture) S 37
C1, C2 (closed2)
W 45
1 Values are for guidance only; different pressure may be ap-
plied according to experimental needs.
2 Ports are closed by clamping Tygon tubes adjacent to the
chip.
To load cells into the chip the procedure below was followed:
1. Set the pressure to the ports as indicated in Table S3.
2. Draw cell suspension in SMM + 0.01% BSA into 20 ml syringe, attach 25Gx5/8” needle
and remove air. Do not leave cells for long in the syringe.
3. Remove the syringe connected to the port W and let the solution drain. Attach the
syringe of cells to the port through 5 cm tube.
4. Clamp tubes adjacent to M1-M4 and S ports to avoid backward flow during cell injec-
tion.
5. Inject cells into the chip. Do not push the plunger too hard. It may take several
minutes until cells reach the chip.
6. Once enough cells are injected (which flow towards C1 and C2 ports), remove the
syringe and replace it with the syringe tube connected to the syringe reservoir with
water + 0.01% BSA.
7. Trap cells in the diffusion chambers by changing the heights of C1/C2 syringe reservoirs.
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8. Once cells are trapped, level the heights of C1/C2 syringe reservoirs (i.e. almost no
flow in cell traps) and adjust their position higher than W syringe reservoir to flush
cells at the C1 and C2 ports.
9. Once C1 and C2 ports are (almost) clear of cells, clamp W port to stop flow.
10. Clamp both tubes adjacent to the C1 and C2 ports (clamp a few places to stop flow
completely), disconnect the longer tubes at the needle adaptors.
11. Remove clamps of M1-M4 and shunt ports.
12. Remove clamp from waste port to start flow.
13. Set height of syringe reservoirs as suggested in Table S3.
14. Adjust the balance of left and right flows by looking at the laminar flow at the split
junction again. Also adjust the balance by looking at loose cells in the chambers by
fine-tuning the M1-M4 syringe reservoir heights.
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Figure 1: An example of diffusion-based gradient with adsorption at steady state. u¯f , con-
centration in solution; u¯a , concentration of adsorbed molecule. A = 2, c1 = 1, c2 = 0, ka =
5,L = 300 (µm).
29
Figure 2: Estimation of diffusion coefficients and error % introduced to the gradient after
isolating a chamber from source/sink channels. (A) Diffusion coefficient D is plotted as
a function of molecular weight (MW). (B) Gradient decay due to diffusion in a confined
chamber of length = 1000 µm. (C) % error introduced after 60 s in chambers of length =
500 µm or 1000 µm.
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Figure 3: Design of microfluidics. (a) Overview of the microfluidics. Main channels (light
blue), chaotic/staggered herringbone mixer (SHM) channels (green) and cell traps (red) are
shown. Black arrows indicate the flow direction for gradient generation and cell culture;
grey arrows indicate the flow direction during cell loading. Flows towards ports C1 and
C2 are stopped after cell loading. Grey rectangles indicate the positions of panels b, c, d
and f. (b) Pseudo-color image of medium flow (Sulforhodamine 101 (SR) in red) at a DAW
junction. (c) Medium flow in SHM channel (SR in red). (d) Overview of the split junction.
Laminar flow (SR in red; Cascade Blue (CB) in blue) at the junction is shown in panel e. (f)
Overview of the diffusion chambers (red) between a pair of parallel channels. The chambers
in the alternative positions have pillars as shown in panel g (SEM image of a silicon wafer
template) for trapping cells. (h) Gradients of two fluorescent tracer dyes (SR, red; CB, blue)
in one of the cell traps indicated in panel f.
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Figure 4: Generation and control of gradients in a diffusion chamber. (a) A schematic of
gradient generation by diffusion. (b, c) Fluorescent dyes were supplied in square waves (b)
for both channels and their fluorescence was measured in the left (c, upper panel) and right
channels (c, lower panel) over time. Arrows in c, upper panel, indicate the fluorescence SR
signal bleed-through in the detected CB fluorescence (see Supplementary material Section 3).
(d, e) The fluorescence intensity measured along the chamber over time. (f, h) Fluorescence
across the chamber was measured every 10 s over 100 s periods, which are highlighted as
grey bars in panels b and c. (g, i) Numerical simulations of fluorescence intensity profiles
(10 s intervals, over 100 s period) corresponding to the measured ones in panels f and h,
respectively. The direction of the change in gradient profiles are indicated by red or blue
arrows in panels f to i. Parameters: c1 = 1, c2 = 0, ka = 5, A = 2 (for SR) or c1 = 0, c2 = 2
(for CB), with diffusion coefficients as mentioned in the text.
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Figure 5: Generation of gradient of FITC-dextran. (a) Fluorescent dyes were supplied in
square waves (upper panel; FD in the left and CB in the right channel) and fluorescence in
the left and right channels were measured (lower panel). Arrows in the lower panel indicate
the bleed-through of FD signal detected as the CB fluorescence. (b) Schematic illustration of
inward flow trajectories at the edge of the chamber. The area of inward flow is indicated by
a double headed arrow. (c) Contour plots of fluorescence level across the chamber (100 µm x
500 µm). The advection dominated areas are indicated by black arrows. (d, f) Fluorescence
across the chamber was measured every 10 s over 100 s periods highlighted in grey bars in
panel a, and plotted. In panel d, linear CB gradient at t = 400 s is also shown. (e, g)
Predicted gradient by diffusion over 100 s period (10 s intervals) after the input is switched
on (e) or off (g). The direction of the change in gradient profiles are indicated by grey arrows
in panes d to g. Diffusion coefficient = 89.7 µm2 s−1 was used for the calculation.
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Figure 6: Generation of a dynamic gradient. (a) CB fluorescence in the left and right
channels over time. The top and bottom of the trapezoid fluorescence signals correspond to
mixing ratio = 1 and 0, respectively. (b, c) The profile of CB fluorescence across one of the
300 µm chambers at the indicated time points.
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Figure 7: Fluorescent reporter protein expression in yeast in response to the gradient of an
inducer. The chamber length is 400 µm. (a) Phase contrast (Ph) and Venus fluorescence
images are shown for the indicated time points. Doxycycline (Dox) concentration are also
indicated for each image pair. Red arrowheads indicate the position of approximate boundary
of expression at T = 2121 min. The low expression of Venus in the region indicated by a red
bracket is likely due to Dox diffused from upstream cell traps. (b) Profile of CB fluorescence
on the image (along the yellow line, above) is plotted (bottom). The image was taken at
2670 min. Bright fluorescence indicates dead cells.
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Figure S1: Different designs of the split junction. (a, b, c) show CAD image of each design.
The design v9 has no separation wall, which resulted in extensive diffusive mixing at the
laminar interface as shown in panel d (purple area).
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Figure S2: Gradient dynamics in response to square wave signals. (a) Fluorescence of CB
in the left and right channels over time. (b) Fluorescence profile across the chamber at the
indicated time points.
37
Figure S3: Bleeding of SR fluorescence during CB signal detection. (A) Fluorescence of SR
(red) and CB (blue) in the left and right channels over time. Arrows indicate signal bleeding
of SR during CB signal detection. (B) Fluorescence profile across the chamber at t = 740 s
and t = 960 s. The fluorescence profile of CB shifted as SR fluorescence decreased, indicating
the bleeding of the SR fluorescence.
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Figure S4: Inducible fluorescent protein reporter expression in yeast cells in a microfluidic
chamber. Images (phase contrast (Ph) and Venus) at the indicated time points during the
entire course of an experiment are shown. The positions of the expression boundary in the
gradient of 0.2-0 µg/ml are indicated by red arrowheads. Fig. 7 in the main text is an
abridged version of the images shown here. Dox concentrations in the left and right channels
are also indicated.
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Figure S5: Fluorescent reporter protein expression in yeast in response to the gradient of an
inducer. The chamber lengths are 300 µm (A) and 600 µm (B). Phase contrast (Ph), Venus,
and CB fluorescence images are shown. Bright fluorescence in the image of CB indicates
dead cells. Profiles of CB fluorescence (along the yellow line) are also plotted. The image
was taken at the indicated time points (the reference time point 0 min is the same as in Fig.
S4).
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Figure S6: Fluorescent protein reporter expression with various carbon sources. (A, C)
Schematics of the inducible expression systems: A, Tet-On system; C, activator/repressor
dual system. (B) Expression of yVenus reporter fluorescent protein by the Tet-On system in
the absence or presence of doxycycline (Dox). (D) Induction of the reporter gene expression
by the dual system in the absence or presence of Dox. Note the background expression of the
reporter is suppressed by TetR-Ssn6 in the absence of Dox. In B and D, each pair of panels are
phase contrast (left panel) and fluorescence (yVenus, right panel) images. Keys: ADH1 and
TEF, constitutively active promoters; rtTA, Dox-inducible transcriptional activator; TetR-
Ssn6, a synthetic transcriptional repressor; TetO7-CYC1TATA, the inducible promoter of
Tet-On system.
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Figure S7: The device setup. (A) Schematic of the system overview. (B) Microfluidic device
attached to a syringe for priming/wetting channels. Note the solution flowing out from the
ports. (C) Flow of CB at the DAW junction at various mixing ratio. Fluorescence was
measured at the rectangular region indicated, and plotted in D (orange dots). (D) The
actuator was programmed to produce triangle wave of CB (blue line). The fluorescence
intensity fits well to this input over time.
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